ANIX stock icon

Anixa Biosciences
ANIX

$2.77
10.36%
 

About: Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Employees: 6

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 3 analysts
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

200% more call options, than puts

Call options by funds: $228K | Put options by funds: $76K

186% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 7

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2.2% more ownership

Funds ownership: 14.2% [Q4 2023] → 16.39% (+2.2%) [Q1 2024]

2% more funds holding

Funds holding: 54 [Q4 2023] → 55 (+1) [Q1 2024]

5% less capital invested

Capital invested by funds: $17.1M [Q4 2023] → $16.3M (-$797K) [Q1 2024]

Research analyst outlook

3 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$7
153%
upside
Avg. target
$10.33
273%
upside
High target
$12
333%
upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Yi Chen
153%upside
$7
Buy
Maintained
10 Jun 2024
HC Wainwright & Co.
Yi Chen
333%upside
$12
Buy
Reiterated
21 Mar 2024
HC Wainwright & Co.
Yi Chen
333%upside
$12
Buy
Reiterated
13 Feb 2024

Financial journalist opinion